This edition includes research on the mental health outcomes of cancer patients, cardiovascular disease risk for people with latent TB, and a cost analysis of two treatments for prescription-type opioid use disorder.
Read More
CHÉOS researchers provide guidance to policymakers on setting pricing tiers to improve overall societal welfare
Read More
Thrombosis is a common side-effect of cancer treatment, but patients are often unaware of the signs and symptoms to look out for
Read More
Event
Conference
September 15, 2022 @ 6:00 pm
Features a presentation from CHÉOS Scientist Dr. Ricky Turgeon on 'What Medications Actually Work for Patients with Heart Failure WITHOUT Reduced Ejection Fraction?'
Read More
Spring 2022 WiPs highlighted the research of CHÉOS Scientists Drs. Alana Flexman, Nick Bansback, Mark Harrison, Ricky Turgeon & Mary De Vera.
Read More
Event
Work in Progress Seminar Series
May 11, 2022 @ 12:00 pm
Identifying & predicting medication adherence trajectories in patients after heart attack: Challenges & implications
Read More